2009 World Stem Cell Summit Company Profile

08:10 EST 11th December 2018 | BioPortfolio

News Articles [3505 Associated News Articles listed on BioPortfolio]

Parkinson’s Disease Patient in World First Stem Cell Therapy

Media Advisory: The New York Stem Cell Foundation Conference

(New York Stem Cell Foundation) The New York Stem Cell Foundation (NYSCF)'s 13th annual translational stem cell research conference convenes global leaders in stem cell research to present their lates...

PTV News: Oct 16, 2009

Top stories on October 16th, 2009: Closure: the Pfizer-Wyeth effect on jobs and drug discovery Baxter: strong earnings, flat sales Going cheap - the big pharmamanufacturing sell-off Survival ...

PTV News: Sep 8, 2009

Top stories on September 8th, 2009: The new man at the helm of Roche's drugs division Hopes raised for an HIV vaccine Bayer's deal with Noway's Algeta Obama's make or break speech on healthcare re...

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

PTV News: Oct 26, 2009

Top stories on October 26th, 2009: Lobbying to  save The Medicines Company US$1B Novo Nordisk's surprise obesity drug Alcon eyes Potentia in macular degeneration deal Pfizer's hunt for Indian par...

Collaboration aims to enhance stem cell selection, expansion

Cellect Biotherapeutics and South Korean biotech Cell2in will collaborate on improving stem cell quality used for stem cell t -More- 

Investing in Stem Cell Treatments

Stem cell treatments have grabbed investor attention for years, but can be be complex and a dangerous treatment. Here is an overview of investing in stem cell treatments. The post Investing in Stem Ce...

PubMed Articles [5992 Associated PubMed Articles listed on BioPortfolio]

The Second Society for Simulation in Healthcare Research Summit: Beyond our Boundaries.

In this article, we report on the Second Society for Simulation in Healthcare Research Summit held in 2017. This meeting succeeded the First Research Summit from 2011 with the goal of advancing the sc...

State performance in pluripotent and adult stem cell research, 2009-2016.

To examine how the geographic distribution of pluripotent and adult stem cell research publications within the USA differs from other areas of biomedical research.

Muscling in on the Awesome Proliferative Power of the Terrible Teratoma.

In this issue of Cell Stem Cell, Chan et al. (2018) report that in vivo differentiation of pluripotent stem cells in induced teratomas produces functional embryonic-like muscle stem cells. These pur...

Intestinal Stem Cell Dynamics: A Story of Mice and Humans.

Stem cell dynamics define the probability of accumulating mutations within the intestinal epithelium. In this issue of Cell Stem Cell, Nicholson et al. (2018) report that human intestinal stem cell d...

Treating Age-Related Diseases with Somatic Stem Cells.

Life expectancy in the developed world has advanced beyond the number of years in which healthy tissue homeostasis can be maintained, and as a result, the number of persons with severe and debilitatin...

Clinical Trials [9648 Associated Clinical Trials listed on BioPortfolio]

Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement

Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty

Yearly Strain Variation Study, 2009/2010

The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Uni...

Regenerative Stem Cell Therapy for Stroke in Europe 1 ( )

Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, and secondary health problems affecting not only patients but also ...

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

The purpose of this first-in-human study of CX-2009 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-2009 in adult sub...

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

The investigators hypothesize that this study will show that sufficient lymphocyte stem cell can be harvested prior chemoradiation and be reinfused back after treatment, and at least 5 of ...

Companies [2336 Associated Companies listed on BioPortfolio]

2009 World Stem Cell Summit

Genetics Policy Institute

GPI is a 501c3 nonprofit foundation with the mission to promote and defend stem cell research and its application in medicine to develop therapeutics and cures for many oth...

Stem Cell Summit

The New York Stem Cell Foundation

The New York Stem Cell Foundation (NYSCF) is an independent organization founded in 2005 to accelerate cures and better treatments for patients through stem cell research. NYSCF, ...

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers ge...

More Information about "2009 World Stem Cell Summit" on BioPortfolio

We have published hundreds of 2009 World Stem Cell Summit news stories on BioPortfolio along with dozens of 2009 World Stem Cell Summit Clinical Trials and PubMed Articles about 2009 World Stem Cell Summit for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 2009 World Stem Cell Summit Companies in our database. You can also find out about relevant 2009 World Stem Cell Summit Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record